Analysis, Sample Size, and Power for Estimating Incremental Net Health Benefit from Clinical Trial Data
- 1 April 2001
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 22 (3) , 228-237
- https://doi.org/10.1016/s0197-2456(01)00110-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Carrier Screening for Cystic FibrosisMedical Decision Making, 1998
- Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimationHealth Economics, 1997
- Users' Guides to the Medical LiteratureJAMA, 1997
- Users' Guides to the Medical LiteratureJAMA, 1997
- Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four MethodsHealth Economics, 1997
- ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIALStatistics in Medicine, 1996
- Confidence intervals for cost-effectiveness ratios: An application of Fieller's theoremHealth Economics, 1996
- Confidence intervals for cost/effectiveness ratiosHealth Economics, 1995
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994